Caudatin inhibits human hepatoma cell growth and metastasis through modulation of the Wnt/β-catenin pathway

Luo,Yi; Sun,Zhiguang; Li,Youbin; Liu,Lina; Cai,Xueting; Li,Zhenlin

doi:10.3892/or.2013.2749

Caudatin inhibits human hepatoma cell growth and metastasis through modulation of the Wnt/β-catenin pathway

Authors:
- Yi Luo
- Zhiguang Sun
- Youbin Li
- Lina Liu
- Xueting Cai
- Zhenlin Li
View Affiliations

Affiliations: Institute of First Clinical Medicine, Nanjing University of Chinese Medicine, Nanjing, Jiangsu 210046, P.R. China, Laboratory of Traditional Chinese Medicine Chemistry, Jiangsu Province Institute of Traditional Chinese Medicine, Nanjing, Jiangsu 210028, P.R. China, Laboratory of Cellular and Molecular Biology, Jiangsu Province Institute of Traditional Chinese Medicine, Nanjing, Jiangsu 210028, P.R. China
Published online on: September 20, 2013 https://doi.org/10.3892/or.2013.2749
Pages: 2923-2928

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

In the present study, we investigated the antitumor activity of caudatin in the human hepatoma cell line SMMC‑7721 by analysis of cell viability, cell cycle distribution, apoptosis and metastasis. The results showed that caudatin impaired the cell viability and inhibited the growth of SMMC-7721 cells in a time- and dose-dependent manner and resulted in cell cycle arrest in the G2 phase. In addition, SMMC-7721 cells, treated with caudatin exhibited typical characteristics of apoptosis. Furthermore, caudatin treatment resulted in a decrease in β-catenin and GSK3β in SMMC-7721 cells, with a concomitant reduction in metastatic capability and expression of Wnt signaling pathway targeted genes including cox-2, mmp-2 and mmp-9. Our findings revealed that caudatin inhibits human hepatoma cell growth and metastasis by targeting the GSK3β/β-catenin pathway and suppressing VEGF production.

View Figures

View References

1	O’Brien K, Cokkinides V, Jemal A, et al: Cancer statistics for Hispanics, 2003. CA Cancer J Clin. 53:208–226. 2003.
2	Bruix J and Sherman M: Management of hepatocellular carcinoma: an update. Hepatology. 53:1020–1022. 2011. View Article : Google Scholar : PubMed/NCBI
3	Bruix J, Raoul JL, Sherman M, et al: Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: subanalyses of a phase III trial. J Hepatol. 57:821–829. 2012. View Article : Google Scholar : PubMed/NCBI
4	Llovet JM, Ricci S, Mazzaferro V, et al: Sorafenib in advanced hepatocellular carcinoma. N Engl J Med. 359:378–390. 2008. View Article : Google Scholar : PubMed/NCBI
5	Su M, Wu X, Chung HY, Li Y and Ye W: Antiproliferative activities of five Chinese medicinal herbs and active compounds in Elephantopus scaber. Nat Prod Commun. 4:1025–1030. 2009.PubMed/NCBI
6	Chang C, Zhu Y, Tang X and Tao W: The anti-proliferative effects of norcantharidin on human HepG2 cells in cell culture. Mol Biol Rep. 38:163–169. 2011. View Article : Google Scholar : PubMed/NCBI
7	Lee MK, Yeo H, Kim J, Markelonis GJ, Oh TH and Kim YC: Cynandione A from Cynanchum wilfordii protects cultured cortical neurons from toxicity induced by H₂O₂, L-glutamate, and kainate. J Neurosci Res. 59:259–264. 2000.
8	Lee MK, Yeo H, Kim J and Kim YC: Protection of rat hepatocytes exposed to CCl₄ in-vitro by cynandione A, a biacetophenone from Cynanchum wilfordii. J Pharm Pharmacol. 52:341–345. 2000. View Article : Google Scholar : PubMed/NCBI
9	Peng YR, Ding YF, Wei YJ, Shu B, Li YB and Liu XD: Caudatin-2,6-dideoxy-3-O-methy-β-D-cymaropyranoside 1 induced apoptosis through caspase 3-dependent pathway in human hepatoma cell line SMMC-7721. Phytother Res. 25:631–637. 2011.
10	Zhang JF, Li YB, Li CL and Jiang JQ: Studies on chemical constituents in root tuber of Cynanchum auriculatum. Zhongguo Zhong Yao Za Zhi. 31:814–816. 2006.(In Chinese).
11	Pongracz JE and Stockley RA: Wnt signalling in lung development and diseases. Respir Res. 7:152006. View Article : Google Scholar : PubMed/NCBI
12	MacDonald BT, Tamai K and He X: Wnt/β-catenin signaling: components, mechanisms, and diseases. Dev Cell. 17:9–26. 2009.
13	Behari J: The Wnt/β-catenin signaling pathway in liver biology and disease. Expert Rev Gastroenterol Hepatol. 4:745–756. 2010.
14	El Wakil A and Lalli E: The Wnt/beta-catenin pathway in adrenocortical development and cancer. Mol Cell Endocrinol. 332:32–37. 2011.PubMed/NCBI
15	Monga SP: Role of Wnt/β-catenin signaling in liver metabolism and cancer. Int J Biochem Cell Biol. 43:1021–1029. 2011.
16	Xiong F, Leonov S, Howard AC, et al: Receptor for advanced glycation end products (RAGE) prevents endothelial cell membrane resealing and regulates F-actin remodeling in a β-catenin-dependent manner. J Biol Chem. 286:35061–35070. 2011.PubMed/NCBI
17	Goodwin AM and D’Amore PA: Wnt signaling in the vasculature. Angiogenesis. 5:1–9. 2002. View Article : Google Scholar : PubMed/NCBI
18	Mei JM, Borchert GL, Donald SP and Phang JM: Matrix metalloproteinase(s) mediate(s) NO-induced dissociation of β-catenin from membrane bound E-cadherin and formation of nuclear beta-catenin/LEF-1 complex. Carcinogenesis. 23:2119–2122. 2002.PubMed/NCBI
19	Arii S, Mise M, Harada T, et al: Overexpression of matrix metalloproteinase 9 gene in hepatocellular carcinoma with invasive potential. Hepatology. 24:316–322. 1996. View Article : Google Scholar : PubMed/NCBI
20	Kamel L, Nessim I, Abd-el-Hady A, Ghali A and Ismail A: Assessment of the clinical significance of serum vascular endothelial growth factor and matrix metalloproteinase-9 in patients with hepatocellular carcinoma. J Egypt Soc Parasitol. 35:875–890. 2005.
21	Zhang X, Gaspard JP and Chung DC: Regulation of vascular endothelial growth factor by the Wnt and K-ras pathways in colonic neoplasia. Cancer Res. 61:6050–6054. 2001.PubMed/NCBI
22	Baryawno N, Sveinbjornsson B, Eksborg S, Chen CS, Kogner P and Johnsen JI: Small-molecule inhibitors of phosphatidylinositol 3-kinase/Akt signaling inhibit Wnt/β-catenin pathway cross-talk and suppress medulloblastoma growth. Cancer Res. 70:266–276. 2010.PubMed/NCBI
23	Tung JN, Chiang CC, Tsai YY, et al: CyclinD1 protein expressed in pterygia is associated with β-catenin protein localization. Mol Vis. 16:2733–2738. 2010.PubMed/NCBI
24	Zhang JY, Tao LY, Liang YJ, et al: Secalonic acid D induced leukemia cell apoptosis and cell cycle arrest of G(1) with involvement of GSK-3β/β-catenin/c-Myc pathway. Cell Cycle. 8:2444–2450. 2009.PubMed/NCBI